Andera Partners — 13F Holdings

2026 Q1  ·  7 Positions

2026 Q1 Portfolio Activity

In 2026 Q1, Andera Partners maintained a portfolio of 7 distinct positions. The most significant new addition was AGOMAB THERAPEUTICS NV, now representing 9.12% of the total fund value. They heavily accumulated shares in KESTRA MED TECHNOLOGIES LTD, increasing the position by 6.1%.
Position History hover any row below to update
Loading…
Andera Partners Paris Private Equity AUM $177M
Fund Overview SEC EDGAR
PCA Score Concentration Risk
Risk ENB
To Excel To CSV
Total Positions
7
Quarter
2026 Q1
Top Holding
KMTS (30.4%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-7 of 7
Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
KMTS
KESTRA MED TECH...
Healthcare 30.36% 38.14% #1
Prev: #1
8.0
—
155,086 6.1%
P
S
2,695,192 $53,715,177
$26.14 -27.0%
$19.93 -4.3%
2025 Q4 13F Filing 2026-03-31 2026-05-11
EVMN
EVOMMUNE INC
Healthcare 24.66% 18.39% #2 1
Prev: #3
6.5
—
no change no change
P
S
1,897,362 $43,620,352 2025 Q4 13F Filing 2026-03-31 2026-05-11
MLYS
MINERALYS THERA...
Healthcare 24.38% 32.71% #3 1
Prev: #2
6.0
—
no change no change
P
S
1,591,917 $43,125,032 2025 Q4 13F Filing 2026-03-31 2026-05-11
N/A
AGOMAB THERAPEU...
Unknown 9.12% — #4
Prev: #—
7.6
—
1,538,702 —
NEW
 1,538,702 $16,140,984 — 13F Filing 2026-03-31 2026-05-11
IVA
INVENTIVA SA
Healthcare 5.70% 4.79% #5
Prev: #5
3.8
—
no change no change
P
S
1,818,181 $10,090,905 2025 Q4 13F Filing 2026-03-31 2026-05-11
ABVX
ABIVAX SA
Healthcare 4.92% 5.97% #6 2
Prev: #4
3.0
—
no change no change
P
S
78,125 $8,699,219 2025 Q4 13F Filing 2026-03-31 2026-05-11
NYXH
NYXOAH S A
Healthcare 0.86% — #7
Prev: #—
3.8
—
522,057 —
NEW
 522,057 $1,524,406 2026 Q1 13F Filing 2026-03-31 2026-05-11
Showing 1-7 of 7 holdings

Unlock Full Andera Partners Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Upgrade to PRO
Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →